Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death

Research output: Contribution to journalArticle


In hereditary Huntington's disease, a triplet repeat disease, there is extensive loss of striatal neurons. It has been shown that brain-derived neurotrophic factor (BDNF) protects striatal neurons against a variety of insults. We confirmed that BDNF enhances survival and DARPP-32 expression in primary striatal cultures derived from postnatal mice. Furthermore, BDNF inhibited intracellular oxyradical stress triggered by dopamine, and partially blocked basal and dopamine-induced apoptosis. Nevertheless, BDNF failed to rescue striatal neurons from dopamine-induced cell death. Therefore, BDNF inhibits free radical and apoptotic pathways in medium spiny neurons, but does so downstream from the point of commitment to cell death.


  • Åsa Petersén
  • K E Larsen
  • G G Behr
  • N Romero
  • S Przedborski
  • Patrik Brundin
  • D Sulzer
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurosciences


  • Huntington’s disease, Autophagy, DARPP-32, Medium spiny neuron
Original languageEnglish
Pages (from-to)331-335
JournalBrain Research Bulletin
Issue number3-4
Publication statusPublished - 2001
Publication categoryResearch

Bibliographic note

The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Neuronal Survival (013212041), Translational Neuroendocrinology (013210010)